… Clarification of the individual meaning of cost and benefit of anticancer treatment played a
prominent role in our results. These factors are less addressed in traditional DAs. Our findings …

… The increasing availability of oral MTAs is transforming the management of incurable cancer;
blurring boundaries between active treatment and palliative care. No studies specifically …

… Patients receiving EOL anticancer treatments often experience belated palliative care referrals.
The use of systemic chemotherapy in patients with advanced cancer and poor prognosis …

… systemic anticancer treatment (SACT) … palliative care (PC) and communication science. We
compiled decisional factors (DFs) important for guiding the use of SACT with palliative intent (…

… influencing the utilization of anticancer treatments, reveal that there … of palliative care into
oncology services significantly correlated with a reduced risk of receiving anticancer treatments, …

… Whether patients are receiving anticancer treatments such as palliative chemotherapy or …
Palliative chemotherapy and radiation (given with the intent to palliate symptoms and/or …

… Among patients who received versus did not receive earlier specialty PC, there were no
differences in the incidence of anti-cancer treatment (P=0.44) or palliative RT (P=1.00) within the …

… often treated with a variety of systemic anti-cancer therapy (SACT) agents with palliative
intent. … Involvement of palliative care is associated with decreased inappropriate use of SACT, …

… % accounted for curative intent, 8.6% for palliative intent, and … For curative and palliative
intent, we examined all patients … , such as the Systemic Anti-Cancer Therapy Dataset collated by …

… and neck cancer with palliative intent. Predicting outcome is … treated with palliative intent.
Methods. The clinical records of all head and neck cancer patients treated with palliative intent …